Technical analysis of Drugs Made In America Acquisition II Corp. (DMIIR): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
Price Performance
| 1 month | -10.39% |
| 3 months | -11.56% |
| Year-to-date | -51.93% |
52-Week Range
| 52-week High | $0.17 |
| 52-week Low | $0.06 |
| Avg Volume (90d) | 12K |
Technical Indicators
| SMA 50 | $0.08 |
| Beta | 4.70 |
| 30-day Volatility (annualised) | 221.5% |
| Price vs SMA 50 | -17.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $0.14 | |
| 2026-01 | $0.12 | -14.3% |
| 2026-02 | $0.13 | +8.3% |
| 2026-03 | $0.08 | -38.5% |
| 2026-04 | $0.09 | +12.5% |
| 2026-05 | $0.08 | -12.1% |
| 2026-06 | $0.08 | +1.1% |
| 2026-07 | $0.08 | +0.0% |
| 2026-08 | $0.07 | -6.3% |
| 2026-09 | $0.07 | -10.3% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-16 | | |
| 2026-09-16 | | |
| 2026-09-16 | | |
| 2026-09-16 | | |
| 2026-09-16 | $-0.07 | $51M |
| 2026-09-16 | | $5M |
Price
| Price | $0.07 |
| Market Cap | $5M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 0.40 |
| Price / Book | 0.01 |
| EV / EBITDA | -5.24 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 0.34 |